Fingerprint
Dive into the research topics of 'Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL
Bodvael Pennarun, Jan H. Kleibeuker, Wytske Boersma-van Ek, Frank A. E. Kruyt, Harry Hollema, Elisabeth G. E. de Vries, Steven de Jong*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
31
Citations
(Scopus)